TIFF Advisory Services’s GoodRx Holdings GDRX Stock Holding History

TIFF Advisory Services’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-146,551	Closed	-$868K	–	25
2022 Q2	$868K	Buy	+146,551	New	+$1.63M	0.31%	20
2021 Q1	–	Sell	-535,965	Closed	-$25.7M	–	23
2020 Q4	$25.7M	Buy	+535,965	New	+$24.6M	8.44%	2

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LSCM

Light Street Capital Management Palo Alto, California $534M AUM 59.08% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

SLG

Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PTC

Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCMX

Technology Crossover Management X Menlo Park, California $781M AUM 18.39% 1-Year Est. Return

TIFF Advisory Services's GDRX Position: Q3 2022 in Review

TIFF Advisory Services sold out of GoodRx Holdings (GDRX) in Q3 2022, closing a stake of 146,551 shares — an estimated $868K sold.

TIFF Advisory Services first reported a position in GDRX in Q4 2020 and held it in 2 quarters. The position peaked at $25.7M in Q4 2020. 180 funds tracked by Wall St. Rank hold GDRX as of Q3 2022.

TIFF Advisory Services reported no remaining GoodRx Holdings position as of Q3 2022 after selling out during the quarter.
TIFF Advisory Services sold 146,551 GoodRx Holdings shares in Q3 2022, an estimated $868K.
TIFF Advisory Services first reported a position in GoodRx Holdings in Q4 2020 and held it in 2 quarters.
TIFF Advisory Services's GoodRx Holdings position peaked at $25.7M in Q4 2020.
180 funds tracked by Wall St. Rank held GoodRx Holdings as of Q3 2022.

Based on TIFF Advisory Services's 13F filing for Q3 2022, filed 10 Nov 2022.